Trinity Biotech plc

Historical 13F Holders

Symbol
TRIB
CUSIP
896438504
All holders as of
Q2 2026
Type
Equity
Class
SPONS ADR NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 896438504 since 12/18/2024, newest first.

Filer % of Class Filed
Perceptive Advisors LLC 13D/A Amendment 8
9.9% 5/4/2026
Event 4/30/2026
Perceptive Advisors LLC 13D/A Amendment 7
9.9% 1/26/2026
Event 1/22/2026
Perceptive Advisors LLC 13D/A Amendment 6
9.9% 12/23/2025
Event 12/22/2025
DAYLI Partners, Inc. 13D/A Amendment 7
0% 12/15/2025
Event 12/2/2025
MiCo IVD Holdings, LLC 13D/A Amendment 6
17.0% 12/10/2025
Event 12/8/2025
MiCo IVD Holdings, LLC 13D/A Amendment 5
17.0% 12/4/2025
Event 12/2/2025
Perceptive Advisors LLC 13D/A Amendment 5
22.5% 10/24/2025
Event 10/23/2025
Perceptive Advisors LLC 13D/A Amendment 4
19.8% 3/25/2025
Event 3/21/2025
Perceptive Advisors LLC 13D/A Amendment 3
20.9% 2/14/2025
Event 12/31/2024
New Main Equity Co., Ltd. 13D
0% 12/26/2024
Event 12/20/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 22 1.02 M $388 k
2026 Q1 25 1.07 M $589 k
2025 Q4 31 850 k $673 k
2025 Q3 30 2.70 M $2.81 M
2025 Q2 29 2.56 M $1.66 M
2025 Q1 30 822 k $468 k
2024 Q4 24 2.61 M $2.30 M
2024 Q3 21 2.68 M $2.95 M
2024 Q2 24 2.67 M $5.68 M
2024 Q1 22 2.93 M $5.97 M